Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies.
about
Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein HopComprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYCMolecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.The epigenetics of epithelial-mesenchymal plasticity in cancer.Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate.Retinoids in cancer therapy and chemoprevention: promise meets resistance.RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents.Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia.Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.Regulation of hematopoietic development by ZBTB transcription factors.p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53.Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo.Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
P2860
Q24682945-AA0B231E-B39B-46B8-98E9-DACDC603EA53Q33560429-B886C604-C6C5-4941-8096-F69A4A81F52BQ33654464-A245ADC9-E873-4ED2-834A-6EBE40C25D77Q34310378-F50F8179-CF29-4F83-84E1-F40CD6BF0026Q35186873-E2D6266A-9129-4720-92F1-C86D11EB512EQ35567239-98B2451D-CB32-482A-BE09-2B2B5E7DF115Q36276965-A5CE7C59-8406-4DD6-915E-7F4AE1B534B4Q36653805-7E401524-8477-4876-B845-9325702C6709Q36889146-188EA97C-6099-4C46-B851-82472E61AE15Q38240617-D92A5A5A-02B5-4CE3-BEE8-5C57C463FF8BQ38331050-0D9EC008-20AA-4F08-8114-D39C98406252Q38850477-BBF3C909-52CF-4353-9367-362EBAA6FDBEQ39371481-A8E51623-F982-411A-B41F-76C14527BF4DQ40501526-54723315-F3A7-4AB9-BD9F-3F1EEC6688DCQ46713722-F515BB77-C3A6-4D2A-ABAB-BF39D8A410C0Q58544569-B4493A0B-A741-45D8-A7AD-D4639F687D48
P2860
Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Complete remission through bla ...... in vitro and in vivo studies.
@en
Complete remission through bla ...... in vitro and in vivo studies.
@nl
type
label
Complete remission through bla ...... in vitro and in vivo studies.
@en
Complete remission through bla ...... in vitro and in vivo studies.
@nl
prefLabel
Complete remission through bla ...... in vitro and in vivo studies.
@en
Complete remission through bla ...... in vitro and in vivo studies.
@nl
P2093
P50
P1433
P1476
Complete remission through bla ...... in vitro and in vivo studies.
@en
P2093
Daniela Diverio
Fabrizio Padula
M Stefania De Propris
Maria A Aloe Spiriti
Maria C Petti
Massimo Gentile
Pier Giuseppe Pelicci
Roberto Fiorini
P304
P356
10.1182/BLOOD-2001-12-0368
P407
P577
2002-08-01T00:00:00Z